FTC Seeks Comment on Drug Company Settlement Deal
Published Date: 6/23/2026
Notice
Summary
The Federal Trade Commission is asking for your thoughts on a deal with Aurobindo and Lannett, two drug companies accused of unfair competition. The companies agree to stop certain practices that hurt competition, helping keep medicine prices fair. You have until July 23, 2026, to share your opinion before the deal is final.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Divestiture to Restore Drug Competition
The FTC says Aurobindo's proposed $250 million acquisition of Lannett could raise prices for four generic medicines, so the companies must sell all rights and assets for those products to Quagen Pharmaceuticals Inc. The four products are mycophenolate mofetil oral suspension, niacin extended release tablets, pilocarpine tablets, and rabeprazole sodium delayed release tablets. The Consent Agreement requires the divestitures no later than 10 days after the Acquisition closes, and if Quagen is unacceptable the sellers must unwind and divest to a Commission-approved buyer within six months.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-12503 — Agency Information Collection Activities; Proposed Collection; Comment Request; Extension
The Federal Trade Commission wants to keep its rule that makes businesses share warranty info before you buy for three more years. This affects thousands of manufacturers and retailers who spend millions of hours and dollars making sure you get clear warranty details. If you have thoughts, speak up by July 22, 2026, before the rule’s current approval ends on July 31.
2026-11635 — Ascension Health Alliance; Analysis of Proposed Agreement Containing Consent Orders To Aid Public Comment
The Federal Trade Commission is reviewing a deal with Ascension Health Alliance to stop unfair competition practices. This affects Ascension and its healthcare partners, aiming to keep the market fair and open. People have until July 10, 2026, to share their thoughts before the deal is finalized—no money changes hands, just rules to play fair.
2026-11114 — Privacy Act of 1974; System of Records
The FTC is updating its Privacy Act records notice to make it clearer and more accurate. This affects anyone whose info is in the FTC’s systems, like consumer complaints or Do Not Call lists. The changes take effect on June 3, 2026, with no extra costs involved—just better info protection and transparency!
2026-10548 — CMG Media Corporation; Analysis of Proposed Consent Order To Aid Public Comment
CMG Media Corporation is facing charges for unfair or tricky business practices, and they’ve agreed to stop these actions through a new deal with the government. People can share their thoughts on this agreement until June 29, 2026. This means CMG Media must change how they operate, and the public gets a say before it’s final.
2026-10547 — 1010 Digital Works LLC; Analysis of Proposed Consent Order To Aid Public Comment
1010 Digital Works LLC is facing charges for unfair or tricky business practices, and they’ve agreed to stop these actions under a new deal. The public can share their thoughts on this agreement until June 29, 2026. This means 1010 Digital must clean up its act, and everyone gets a say before the deal is final.
2026-10546 — MindSift LLC; Analysis of Proposed Consent Order To Aid Public Comment
MindSift LLC is facing claims for unfair or tricky business practices, and they’ve agreed to stop these actions through a new deal with the Federal Trade Commission. The public can share their thoughts on this agreement until June 29, 2026. This means MindSift must change how they operate soon, or face further action.
Previous / Next Documents
Previous: 2026-12611 — Notice of Receipt of Complaint; Solicitation of Comments Relating to the Public Interest
The U.S. International Trade Commission got a complaint about certain battery materials imported from China that might break trade rules. They want to hear from the public and other parties about how this could affect everyone, especially regarding trade and technology. If the complaint moves forward, it could lead to import bans and other actions within about 60 days, possibly impacting businesses and prices.
Next: 2026-12613 — Order Granting Conditional Exemptive Relief, Pursuant to Sections 17A and 36(a) of the Securities Exchange Act of 1934, From the Definition of an “Eligible Secondary Market Transaction” in Rule 17ad-22(a)
The SEC is giving special permission to some U.S. Treasury securities clearing agencies to exclude certain trades between related parties from strict rules about reporting and clearing. This change affects big financial players who trade these securities and helps them avoid extra paperwork for these specific deals. The new rules kick in soon and aim to keep the market smooth without adding extra costs or risks.